INWORKS实体癌死亡率风险估计远高于等效的LSS风险估计。

IF 2.4 4区医学 Q3 PHARMACOLOGY & PHARMACY

Dose-Response Pub Date : 2025-09-22 eCollection Date: 2025-07-01 DOI:10.1177/15593258251382312

Ken Chaplin

引用次数: 0

摘要

INWORKS研究中实体癌死亡率的风险估计值远高于LSS研究1,2然而，一些分析人士通过比较两项研究中不相等的风险估计得出了相反的结论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

INWORKS Solid Cancer Mortality Risk Estimate is Much Higher than the Equivalent LSS Risk Estimate.

Risk estimates for solid cancer mortality are much higher in the INWORKS study than in the LSS study.^1,2 However, some analysts have reached the opposite conclusion by comparing non-equivalent risk estimates in the 2 studies.³.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Dose-Response PHARMACOLOGY & PHARMACY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

CiteScore

4.90

自引率

4.00%

发文量

140

审稿时长

>12 weeks

期刊介绍： Dose-Response is an open access peer-reviewed online journal publishing original findings and commentaries on the occurrence of dose-response relationships across a broad range of disciplines. Particular interest focuses on experimental evidence providing mechanistic understanding of nonlinear dose-response relationships.